1. Home
  2. DNLI vs EFSC Comparison

DNLI vs EFSC Comparison

Compare DNLI & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • EFSC
  • Stock Information
  • Founded
  • DNLI 2013
  • EFSC 1988
  • Country
  • DNLI United States
  • EFSC United States
  • Employees
  • DNLI N/A
  • EFSC N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • EFSC Major Banks
  • Sector
  • DNLI Health Care
  • EFSC Finance
  • Exchange
  • DNLI Nasdaq
  • EFSC Nasdaq
  • Market Cap
  • DNLI 2.3B
  • EFSC 2.2B
  • IPO Year
  • DNLI 2017
  • EFSC 1999
  • Fundamental
  • Price
  • DNLI $15.21
  • EFSC $57.96
  • Analyst Decision
  • DNLI Strong Buy
  • EFSC Strong Buy
  • Analyst Count
  • DNLI 15
  • EFSC 3
  • Target Price
  • DNLI $33.50
  • EFSC $64.33
  • AVG Volume (30 Days)
  • DNLI 2.0M
  • EFSC 155.3K
  • Earning Date
  • DNLI 11-05-2025
  • EFSC 10-27-2025
  • Dividend Yield
  • DNLI N/A
  • EFSC 2.13%
  • EPS Growth
  • DNLI N/A
  • EFSC 15.35
  • EPS
  • DNLI N/A
  • EFSC 5.26
  • Revenue
  • DNLI N/A
  • EFSC $637,581,000.00
  • Revenue This Year
  • DNLI N/A
  • EFSC $18.12
  • Revenue Next Year
  • DNLI $95,463.19
  • EFSC $4.60
  • P/E Ratio
  • DNLI N/A
  • EFSC $11.07
  • Revenue Growth
  • DNLI N/A
  • EFSC 9.46
  • 52 Week Low
  • DNLI $10.57
  • EFSC $45.22
  • 52 Week High
  • DNLI $33.33
  • EFSC $63.13
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 54.76
  • EFSC 50.02
  • Support Level
  • DNLI $15.03
  • EFSC $56.80
  • Resistance Level
  • DNLI $16.51
  • EFSC $58.81
  • Average True Range (ATR)
  • DNLI 0.80
  • EFSC 1.39
  • MACD
  • DNLI 0.11
  • EFSC -0.20
  • Stochastic Oscillator
  • DNLI 61.42
  • EFSC 60.37

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About EFSC Enterprise Financial Services Corporation

Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.

Share on Social Networks: